| Not Yet Recruiting | Characterization of Primary Central Nervous System Diffuse Large B Cell Lymphoma (PCNS-DLBCL) by Multiomic App Primary Central Nervous System Diffuse Large B Cell Lymphoma (PCNS-DLBCL) | — | 2026-04-01 |
| Not Yet Recruiting | Molecular and Cellular Characterization of MALT Lymphoma MALT Lymphoma | — | 2026-04-01 |
| Recruiting | Integrated Molecular and Clinical Profiling of Transformed Splenic Marginal Zone Lymphoma Transformed Splenic Marginal Zone Lymphoma | — | 2025-10-13 |
| Active Not Recruiting | Comparison Between Rituximab Plus Zanubrutinib Versus Rituximab Monotherapy in Untreated SMZL Patients Splenic Marginal Zone Lymphoma | Phase 3 | 2024-05-21 |
| Recruiting | Integrated Molecular and Clinical Profiling to Improve Disease Characterization and Outcome Prediction in Noda Nodal Marginal Zone Lymphoma | — | 2024-04-11 |
| Active Not Recruiting | Pembrolizumab and Radiotherapy for Patients With NK/T Cell Lymphoma Lymphoma, Extranodal NK-T-Cell | Phase 2 | 2022-02-11 |
| Active Not Recruiting | Study of Acalabrutinib and Tafasitamab in MZL Patients Marginal Zone Lymphoma | Phase 2 | 2021-10-20 |
| Active Not Recruiting | FDG PET Evaluation for Marginal Zone Lymphoma and Its Prognostic Role Marginal Zone Lymphoma | — | 2020-12-01 |
| Active Not Recruiting | MALIBU Trial - Combination of Ibrutinib and Rituximab in Untreated Marginal Zone Lymphomas Marginal Zone Lymphoma, Nodal Marginal Zone Lymphoma, Splenic Marginal Zone Lymphoma | Phase 2 | 2019-09-27 |
| Completed | Study on Tailored Treatment in Elderly Patients With Newly Diagnosed Primary Lymphoma of Central Nervous Syste Primary Central Nervous System Lymphoma | Phase 2 | 2019-06-15 |
| Completed | Clarithromycin + Lenalidomide Combination: a Full Oral Treatment for Patients With Relapsed/Refractory Extrano Mucosa Associated Lymphoid Tissue (MALT) Lymphoma | Phase 2 | 2017-04-03 |
| Completed | Integrated Molecular and Clinical Profiling to Optimize Outcome Prediction in Splenic Marginal Zone Lymphoma Splenic Marginal Zone Lymphoma | — | 2017-01-01 |
| Completed | New Combination of Chemoimmunotherapy for Systemic B-cell Lymphoma With Central Nervous System Involvement Diffuse Large B-cell Lymphoma | Phase 2 | 2014-12-01 |
| Active Not Recruiting | Phase II Study of Chlorambucil and Subcutaneous Rituximab in Patients With Extranodal MALT Lymphoma MALT Lymphoma | Phase 2 | 2013-12-01 |
| Active Not Recruiting | Phase II Trial of First-line Doxycycline for Ocular Adnexal Marginal Zone Lymphoma Treatment Marginal Zone Lymphoma of Ocular Adnexal | Phase 2 | 2013-03-01 |
| Active Not Recruiting | Randomized, Open-label, Two-arms, Phase III Comparative Study Assessing the Role of Involved Mediastinal Radio Primary Mediastinal B-cell Lymphoma | N/A | 2012-10-01 |
| Completed | Bendamustine and Rituximab for the Treatment of Splenic Marginal Zone Lymphoma Marginal Zone B-cell Lymphoma | Phase 2 | 2012-07-01 |
| Terminated | This Trial is a Prospective Observational Study of Newly Diagnosed Diffuse Large B Cell Primary Breast Lymphom Diffuse Large B-Cell Lymphoma of the Breast | — | 2011-10-01 |
| Completed | Multicenter Phase II Study to Evaluate the Clinical Activity and the Safety Profile of Everolimus in Marginal Marginal Zone B-cell Lymphoma | Phase 2 | 2010-03-01 |
| Completed | Trial for Patients With Newly Diagnosed Primary Central Nervous System (CNS) Lymphoma Central Nervous System Lymphoma | Phase 2 | 2009-11-01 |
| Completed | Safety and Feasibility Study of Combination of State of Art Chemoimmunotherapy, Intensive Central Nervous Syst Large B-cell Diffuse Lymphoma of Testis | Phase 2 | 2009-09-27 |
| Completed | A Clinico-Pathologic Study of Primary Mediastinal B-Cell Lymphoma Primary Mediastinal B-Cell Lymphoma | — | 2007-01-01 |
| Completed | A Clinico-Pathological Study to Investigate the Possible Infective Causes of Non-Hodgkin Lymphoma of the Ocula Non-Hodgkin Lymphoma | Phase 2 | 2006-09-01 |
| Terminated | VELCADE in MALT Lymphoma Pretreated With More Than One Prior Systemic Therapy Lymphoma, Mucosa-Associated Lymphoid Tissue | Phase 2 | 2005-07-01 |
| Completed | VELCADE in MALT Lymphoma Pretreated With Prior Systemic Therapy Lymphoma, Mucosa-Associated Lymphoid Tissue | Phase 2 | 2005-07-01 |
| Terminated | Salvage Therapy With Idarubicin in Relapsing CNS Lymphoma Lymphoma, B-Cell | Phase 2 | 2004-11-01 |
| Completed | Phase II Trial of Combined Modality Treatment in Primary Central Nervous System Lymphoma Lymphoma, B Cell | Phase 2 | 2003-07-01 |
| Completed | Randomized Trial of Chlorambucil Versus Chlorambucil Plus Rituximab Versus Rituximab in MALT Lymphoma Lymphoma, Mucosa-Associated Lymphoid Tissue | Phase 3 | 2003-01-01 |
| Completed | Phase II Study of Combined Modality Treatment in Primary Testicular Non-Hodgkin's Lymphoma Lymphoma, B Cell | Phase 2 | 2000-11-01 |
| Withdrawn | A Phase I Study of Intrathecal Rituximab in Patients With Lymphomatous Meningitis Lymphoma, B Cell | Phase 1 | — |